# Beiji Zhiyuan

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beiji-zhiyuan

- Industry: Biotechnology
- Headquarters: Beijing, China
- Latest round: Angel (Aug 7, 2026)
- Investors on record: 1

## About

Based in Beijing, China, and founded in 2026, Beijing Beiji Zhiyuan Biotechnology Co., Ltd., trading as Beiji Zhiyuan, focuses on the design and optimization of small molecule drugs driven by quantum annealing and AI/ML. In August 2026, Beiji Zhiyuan raised an Angel funding round.

The company provides AI- and quantum computing-driven drug discovery solutions, leveraging quantum annealing and machine learning technologies to design, optimize, and develop novel small-molecule therapeutics and proprietary drug candidates. It is committed to promoting the industrial application of cutting-edge international drug discovery technologies in Greater China and Southeast Asia.

The company generates revenue by providing AI-powered drug discovery and molecular design services.

The Angel funding raised in August 2026 will be used to support the company's innovative research and development in the fields of quantum annealing and AI/ML-driven small molecule drug design and optimization.

## Funding rounds

- Angel, Aug 7, 2026 — Jinkong Qiyuan Capital

## Investors

- Jinkong Qiyuan Capital (https://capitalatlas.ai/funds/jinkong-qiyuan-capital) — Angel